Drugs / mHACMb
mHACMb
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03441607 Comparator | Nov 2018 → Feb 2019 | osteoarthritis, knee | Applied Biologics, LLC | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mHACMb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03441607 ↗ |
| Known as | 100mg FloGraft (micronized human amnion chorion membrane) | “100mg FloGraft (micronized human amnion chorion membrane)®” NCT03441607 ↗ |
| Known as | 40mg FloGraft (micronized human amnion chorion membrane) | “40mg FloGraft (micronized human amnion chorion membrane)®” NCT03441607 ↗ |
| Known as | FloGraft | “Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee” NCT03441607 ↗ |